Fusion Pharmaceuticals Inc. Current Foreign Tax Expense (Benefit)
Fusion Pharmaceuticals Inc. reported Current Foreign Tax Expense (Benefit) of -$60.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2024-03-20
- Fusion Pharmaceuticals Inc. current foreign tax expense (benefit) for fiscal 2023 was -$60.00K, a 104.54% decline from fiscal 2022.
- Fusion Pharmaceuticals Inc. current foreign tax expense (benefit) for fiscal 2022 was $1.32M, a 51.89% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. current foreign tax expense (benefit) for fiscal 2021 was $871.00K, a 72.59% decline from fiscal 2020.
- Fusion Pharmaceuticals Inc. current foreign tax expense (benefit) for fiscal 2020 was $3.18M, a 1977.12% increase from fiscal 2019.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2023-12-31 | -$60.00K 10-K · filed 2024-03-20 |
| 2022-12-31 | $1.32M 10-K · filed 2024-03-20 |
| 2021-12-31 | $871.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $3.18M 10-K · filed 2022-03-17 |
| 2019-12-31 | $153.00K 10-K · filed 2021-03-25 |